Ms Katarzyna (Kasia) Zmarzly

At Nanovery we are building Nanorobots for sensitive detection of nucleic acid biomarkers in complex samples. Our innovative technology has the potential to significantly impact diagnostics, laboratory, and point of care testing. Our highly sensitive nanorobots can detect traces of nucleic acid markers in complex liquid biological samples with minimal preparation. We are in the process of demonstrating that our technology could be used to simplify the diagnosis of castration-resistant prostate cancer from a patient's blood sample. At this early stage, we require expert advice to ensure our technology meets the needs of the pharmaceutical industry. We would be really interested to hear your views on the use of our nanorobots. I'd love to have a chat with anyone who would like to connect.